Antiretroviral prophylaxis: A defining moment in HIV control

The Lancet

Volumn 378, Issue 9809, 2011, Pages

  Karim, Salim S Abdool ^a,b   Karim, Quarraisha Abdool ^a,b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EMTRICITABINE; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; MICROBICIDE; TENOFOVIR; TENOFOVIR DISOPROXIL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; CONDOM; HEALTH CARE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; NOTE; PATHOGENESIS; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; RISK; SOUTH AFRICA; SURVIVAL;

EID: 83955164274     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61136-7     Document Type: Note

References (15)

1. University of Washington International Clinical Research Center Partners PrEP Study. Press release. Pivotal study finds that HIV medications are highly effective as prophyalxis against HIV infection in men and women in Africa http://depts.washington.edu/uwicrc/research/studies/files/PrEP-PressRelease-UW- 13Jul2011.pdf July 13, 2011 (accessed July 13, 2011).
2. Centers for Diseases Control and Prevention Press release. CDC trial and another major study find PrEP can reduce risk of HIV infection among heterosexuals http://www.cdc.gov/nchhstp/newsroom/PrEPHeterosexuals.html July 13, 2011 (accessed July 13, 2011).
3. Q Abdool Karim, SS Abdool Karim, JA Frohlich et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women Science 329 2010 1168 1174
4. RM Grant, JR Lama, PL Anderson et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men N Engl J Med 363 2010 2587 2599
5. HIV Prevention Trials Network Press release. Initiation of antiretroviral treatment protects uninfected sexual partners from HIV infection (HPTN Study 052) http://www.hptn.org/web20documents/PressReleases/HPTN052PressReleaseFINAL5- 12-118am.pdf May 12, 2011 (accessed May 12, 2011).
6. B Auvert, D Taljaard, E Lagarde, J Sobngwi-Tambekou, R Sitta, A Puren Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial PLoS Med 2 2005 e298
7. RH Gray, G Kigozi, D Serwadda et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial Lancet 369 2009 657 666
8. RC Bailey, S Moses, CB Parker et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial Lancet 369 2007 643 656
9. N Siegfried, M Muller, JJ Deeks, J Volmink Male circumcision for prevention of heterosexual acquisition of HIV in men Cochrane Database Syst Rev 15 2009 CD003362.
10. H Grosskurth, F Mosha, J Todd et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial Lancet 346 1995 530 536
11. S Rerks-Ngarm, P Pitisuttithum, S Nitayaphan et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand N Engl J Med 361 2009 2209 2220
12. Gilead Sciences Inc Gilead expands access program for medications in developing world http://www.gilead.com/pr-1584101 July 12, 2011 (accessed July 15, 2011).
13. FHI statement on the FEM-PrEP HIV Prevention Study http://minilicious. wordpress.com/2011/04/18/fhi-statement-on-the-fem-prep-hiv-prevention-study April 18, 2011 (accessed April 18, 2011).
14. SS Abdool Karim, A Kashuba, L Werner, Q Abdool Karim Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women Lancet 378 2011 279 281
15. SS Abdool Karim Stigma impedes AIDS prevention Nature 474 2011 29 31